Breast cancer is the most common fatal cancer in women. Early detection increases a woman’s chances of recovery. Magnetic resonance imaging (MRI) is an accurate technique for detecting and classifying tumors in breast tissue. However, it sometimes results in “false alarms,” thus requiring further investigation (biopsy) and in some cases, even resulting in unnecessary surgery. For the first time, a research team from MedUni Vienna has now confirmed a threshold value for a non-invasive imaging biomarker. This can be incorporated into short standard MRI scans and could reduce the biopsy rate following MRI scans by 30%. Since the infrastructure for this measurement already exists in every radiological facility in Austria, the biomarker could be immediately deployed countrywide.